Stockreport

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF TEL AVIV, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company [Read more]